DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Venture Capital
Saint Louis, MO
Strategically investing in smarter technologies, bigger data, better alternatives, and healthier futures.
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| Collaborative Health Ventures V, L.P. | 2020 | Mature | $0 | $252M | 0 |
| CHV IV, L.P. | 2017 | Harvest | $0 | $216M | 0 |
| CHV III, L.P. | 2012 | Harvest | $149M | $64.9M | 0 |
| CHV II, L.P. | n/a | Unknown | n/a | $11.2M | 0 |
| Company | State | Stage | Round size | Partner | Attribution | Observed |
|---|---|---|---|---|---|---|
| Accretive Health Nyseah | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Advanced Practice Strategies | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Aethon | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Alignment Healthcare | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Aliphcom Dba Jawbone | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Apama Medical | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Aristamd | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Atigeo Inc | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Augmenix | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Bardy Diagnostics Inc | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Bind | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Bioimagene | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Cala Health, Inc. | CA | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Cardiacbooster | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Cardionomic | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Cedar Gate Technologies | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Censys | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Cheetah Medical | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Nuwellis, Inc. | Mn | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Civitas Solutions | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Cofactor Genomics | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Compassus | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Comprehensive Pharmacy Services | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Confluent Surgical | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Academic Partnerships | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| Investor | Co-investor | Shared deals | Shared companies | Last observed | Strength |
|---|---|---|---|---|---|
| Ascension Ventures | Delos Advisors, Inc. | 3 | 3 | Sep 17, 2026 | Recurring |
| RC Capital | Ascension Ventures | 2 | 2 | Sep 17, 2026 | Recurring |
| Ascension Ventures | Long River Capital Management II LLC | 2 | 2 | Sep 17, 2026 | Recurring |
| Femhealth Ventures Management LLC | Ascension Ventures | 2 | 2 | Sep 17, 2026 | Recurring |
| NEA: New Enterprise Associates | Ascension Ventures | 2 | 2 | Sep 17, 2026 | Recurring |
| Four Rivers Group | Ascension Ventures | 1 | 1 | Sep 17, 2026 | One time |
| OWL Ventures | Ascension Ventures | 1 | 1 | Sep 17, 2026 | One time |
| Echo Health Ventures | Ascension Ventures | 1 | 1 | Sep 17, 2026 | One time |
| Chv | Ascension Ventures | 1 | 1 | Sep 17, 2026 | One time |
| Iselect Fund Management, LLC | Ascension Ventures | 1 | 1 | Sep 17, 2026 | One time |
| Alleycorp Advisers, LLC | Ascension Ventures | 1 | 1 | Sep 17, 2026 | One time |
| AIM Master I (bvi) Ltd. | Ascension Ventures | 1 | 1 | Sep 17, 2026 | One time |
| Catalio Capital Management, LP | Ascension Ventures | 1 | 1 | Sep 17, 2026 | One time |
| 1315 Capital | Ascension Ventures | 1 | 1 | Sep 17, 2026 | One time |
| Ascension Ventures | RA Capital Management, LP | 1 | 1 | Sep 17, 2026 | One time |
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan